Results 221 to 230 of about 1,884,582 (342)

Encouraging GPs to undertake screening and a brief intervention in order to reduce problem drinking: a randomized controlled trial [PDF]

, 1999
Lars J. Hansen, Niels de Fine Olivarius, Anders Beich, Sverre Barfod   +3 more
openalex   +1 more source

In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock, Jihyun Park, Dae‐Gyu Jang, Bangyao Zhao, Samuel J. Teener, Ian F. Webber‐Davis, Lili Zhao, Eva L. Feldman, Stephen A. Goutman   +8 more
wiley   +1 more source

Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double‐blind, placebo‐controlled trial [PDF]

, 1997
James R. O’Dell, Claire E. Haire, William Palmer, Walter Drymalski, Steven Wees, Kent Blakely, Melvin Churchill, P. James Eckhoff, Arthur L. Weaver, Deborah K. Doud, N Erikson, Fred Dietz, Rich Olson, Pierre Maloley, Lynell W. Klassen, Gerald Moore   +15 more
openalex   +1 more source

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li, Binbin Xue, Jia Li, Dewei Xie, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Xu Zhang, Junhui Xia, Jie Lin   +10 more
wiley   +1 more source

Acupuncture with different frequencies for tobacco dependence: a randomized controlled trial. [PDF]

J Tradit Chin Med
Shumin C, Zhenyu L, Jia JI, Jin C, Zhihua LI, Yingying W, Jinsheng Y.   +6 more
europepmc   +1 more source

Individually randomized intervention trials for disease prevention and control [PDF]

, 1999
Garnet L. Anderson, Ross L. Prentice
openalex   +1 more source

Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji, Marcello Moccia, Alessia Bianchi, Charmaine Yam, Weaam Hamed, Suraya Mohamud, Alan J. Thompson, Frederik Barkhof, Ahmed T. Toosy, Olga Ciccarelli   +9 more
wiley   +1 more source

Letter to the Editor Regarding ‘A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts’

Dermatology and Therapy, 2020
Antoine Bertolotti, Christian Derancourt
doaj   +1 more source

Virtual Reality as an Adjunct to Pediatric Cast Removal: A Randomized Controlled Trial. [PDF]

JB JS Open Access
Georgiadis AG, Schavee PE, Koester TM, DeBruin WT, Burkitt CC, Truong WH, Laine JC.   +6 more
europepmc   +1 more source

Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. [PDF]

, 1997
J.‐P. Bonjour, Anne-Lise Carrié, Serge Ferrari, H Clavien, Daniel O. Slosman, G Theintz, René Rizzoli   +6 more
openalex   +1 more source